Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/50282Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Tavitiya Sudjaritruk | en_US |
| dc.contributor.author | Thira Sirisanthana | en_US |
| dc.contributor.author | Virat Sirisanthana | en_US |
| dc.date.accessioned | 2018-09-04T04:27:45Z | - |
| dc.date.available | 2018-09-04T04:27:45Z | - |
| dc.date.issued | 2011-01-01 | en_US |
| dc.identifier.issn | 15320987 | en_US |
| dc.identifier.issn | 08913668 | en_US |
| dc.identifier.other | 2-s2.0-79951679948 | en_US |
| dc.identifier.other | 10.1097/INF.0b013e3181f812f8 | en_US |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79951679948&origin=inward | en_US |
| dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/50282 | - |
| dc.description.abstract | The prevalence of hepatitis A virus (HAV) protective antibody in 98 Thai HIV-infected children who achieved immune recovery after antiretroviral therapy was 12.2%. After a 2-dose HAV vaccination, 98.8% (85 of 86 children) seroconverted. The geometric mean titer was 520.95 mIU/mL. In a multivariate analysis, female gender, age <12 years and higher CD4 lymphocyte count at enrollment were predicting factors for high (≥250 mIU/mL) HAV antibody response. © 2011 Lippincott Williams & Wilkins, Inc. | en_US |
| dc.subject | Medicine | en_US |
| dc.title | Antibody responses to hepatitis A virus vaccination in Thai HIV-infected children with immune recovery after antiretroviral therapy | en_US |
| dc.type | Journal | en_US |
| article.title.sourcetitle | Pediatric Infectious Disease Journal | en_US |
| article.volume | 30 | en_US |
| article.stream.affiliations | Chiang Mai University | en_US |
| Appears in Collections: | CMUL: Journal Articles | |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.